CoSyne Therapeutics

Curated by Signal

Developer of computational AI-based drug discovery platform

Overview

Developer of computational AI-based drug discovery platform. It offers genetic computational paltform for drug development process, spanning target discovery, clinical trials and treating patients with fatal orphan diseases.

Key facts

Founded: 2021
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Onebright
Provider of mental health counseling services
Health TechnologyYork, United Kingdom
Pharmacy Saver
Online telepharmacy store
Health TechnologyStanmore, United Kingdom
Aridhia
Offers a collaborative platform for health and bio medical analytics
Health TechnologyEdinburgh, United Kingdom

About CoSyne Therapeutics

What does CoSyne Therapeutics do?

Developer of computational AI-based drug discovery platform.

Where is CoSyne Therapeutics headquartered?

CoSyne Therapeutics is headquartered in London, United Kingdom.

When was CoSyne Therapeutics founded?

CoSyne Therapeutics was founded in 2021.

Which sector is CoSyne Therapeutics in?

CoSyne Therapeutics operates in Health Technology.

Who are CoSyne Therapeutics's competitors?

Companies similar to CoSyne Therapeutics include Onebright, Pharmacy Saver, and Aridhia.